<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04165759</url>
  </required_header>
  <id_info>
    <org_study_id>PRSHRCT</org_study_id>
    <nct_id>NCT04165759</nct_id>
  </id_info>
  <brief_title>Prospective Radiological Study of HRCT to Predict Pathological Noninvasiveness in NSCLC</brief_title>
  <official_title>Prospective Radiological Study of HRCT to Predict Pathological Noninvasiveness in NSCLC</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fujian Medical University Union Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shandong First Medical University Affiliated Liaocheng Second Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yangzhou Jiangdu People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the correlation between radiological diagnosis based on HRCT and&#xD;
      pathological invasiveness. All enrolled patients receive HRCT examination before surgery.&#xD;
      Investigators observe the radiological features and the correlation with the postoperative&#xD;
      pathological findings.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Radiological findings determines the decision-making about the extent of primary surgical&#xD;
      resection in adenocarcinoma of lung. Previous study showed the diagnosis of AIS/MIA and IAD&#xD;
      based on radiological findings is correlated to the pathological diagnose. The purpose of&#xD;
      this analysis is to define the role of radiological diagnosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 18, 2019</start_date>
  <completion_date type="Actual">July 1, 2021</completion_date>
  <primary_completion_date type="Actual">April 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Specificity and Sensitivity</measure>
    <time_frame>about 14 days</time_frame>
    <description>The specificity and Sensitivity based on the radiological diagnosis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of positive radiological invasiveness</measure>
    <time_frame>about 14 days</time_frame>
    <description>the number of patients with radiological invasiveness diagnosis / total number of patients</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">620</enrollment>
  <condition>Adenocarcinoma of Lung</condition>
  <arm_group>
    <arm_group_label>patients</arm_group_label>
    <description>Patients with lung cancer who are candidates for surgery.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Lung surgical specimens&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        East Asian population&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  pulmonary nodule diagnosed by thoracic CT&#xD;
&#xD;
          -  karnofsky performance status ≥60&#xD;
&#xD;
          -  No surgical contraindication&#xD;
&#xD;
          -  Patients who sign the informed consent&#xD;
&#xD;
          -  Pre-operation clinical stage :T1abcN0M0&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Central lung tumor diagnosed by CT&#xD;
&#xD;
          -  Tracheal or bronchus deformity diagnosed by CT&#xD;
&#xD;
          -  Tracheal or bronchus disease history&#xD;
&#xD;
          -  Severe smoking history #smoking index ≥400/year&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haiquan Chen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fudan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fudan University Cancer Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fudan University Shanghai Cancer Center</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>November 14, 2019</study_first_submitted>
  <study_first_submitted_qc>November 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2019</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fudan University</investigator_affiliation>
    <investigator_full_name>Haiquan Chen</investigator_full_name>
    <investigator_title>Director of Department of thoracic surgery and multidisciplinary group of thoracic oncology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma of Lung</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

